Market Cap 8.12B
Revenue (ttm) 2.57B
Net Income (ttm) -1.84B
EPS (ttm) N/A
PE Ratio 29.57
Forward PE 30.55
Profit Margin -71.86%
Debt to Equity Ratio 0.18
Volume 76,200
Avg Vol 207,218
Day's Range N/A - N/A
Shares Out 26.98M
Stochastic %K 34%
Beta 1.18
Analysts Sell
Price Target $352.50

Company Profile

Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through two segments, Life Science and Clinical Diagnostics. The company develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantitate biological materials, such as cells, proteins, and nucleic acids used in biopharmaceutical manufacturing, q...

Industry: Medical Devices
Sector: Healthcare
Phone: 510 724 7000
Fax: 510 741 5817
Address:
1000 Alfred Nobel Drive, Hercules, United States
DarylFarley1
DarylFarley1 Dec. 25 at 8:35 PM
$BIO $EH $XXRP $EMN High volume bottoming out
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 25 at 2:39 PM
$BIO: Current market context shows a recent close at $301.75 with an RSI of 29.02, indicating oversold conditions. The price is below both the 30-day MA of $312.43 and the 50-day MA of $314.84, suggesting bearish sentiment. However, the substantial gap from the 60-day high of $343.12 presents a potential reversal opportunity. Directional bias leans bullish due to the oversold RSI, which often signals a rebound. The 60-day low of $280.61 provides a solid support level. Trade Plan: - Suggested Entry: $302.50 - Stop Loss: $290.00 (below 60D low for risk management) - Take Profit Targets: 1. $315.00 (5% ROI) 2. $325.00 (7.7% ROI) 3. $353.00 (17% ROI) This plan capitalizes on potential bullish momentum while managing risk effectively. Monitor market conditions closely for any shifts. https://privateprofiteers.com
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Dec. 25 at 1:53 PM
$BIO RSI: 29.02, MACD: -3.5929 Vol: 8.88, MA20: 311.20, MA50: 314.84 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 19 at 4:34 PM
$BIO: Current market context shows a potential reversal opportunity. With the last close at $299.86 and an RSI of 20.56, the stock is significantly oversold, suggesting a bullish bias. The MA30 at $313.22 and MA50 at $314.80 indicate resistance levels above, while the 60D high of $343.12 provides a target for upward movement. Actionable Trade Alert: - Suggested Entry: $300.00 - Stop Loss: $280.00 (7% below entry) - Take Profit Targets: 1. Target 1: $320.00 (6.67% ROI) 2. Target 2: $335.00 (11.67% ROI) 3. Target 3: $350.00 (16.67% ROI) With a favorable risk-reward ratio, this trade plan aims for a minimum 16.67% ROI on the third target. The stock's current position within the high-low range supports potential upside movement. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 17 at 3:21 AM
$BIO: The stock closed at $302.02, with an RSI of 18.32, indicating it is significantly oversold. This suggests a potential reversal, especially given the proximity to the 60D Low of $266.71. The MA30 and MA50 are at $313.88 and $314.77, respectively, indicating resistance levels that could be targets for recovery. Actionable Trade Alert: - Suggested Entry: $302.02 - Stop Loss: $290.00 (3.98% below entry) - Take Profit Targets: 1. $320.00 (5.95% gain) 2. $335.00 (10.90% gain) 3. $353.00 (17.00% gain) Market context shows a potential upward movement as the stock is at a low point, and the RSI suggests a bounce back. The ATR of 8.41 indicates volatility, allowing for wider price movements. The directional bias is bullish due to the oversold condition and potential for recovery towards the MA levels. For further insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 15 at 6:53 AM
$BIO Actionable Trade Alert: Market Context: $BIO is currently trading at $308.13, below both the 30-day (MA30) and 50-day (MA50) moving averages, indicating a bearish trend. The RSI at 42.49 suggests the stock is nearing oversold territory, which could signal a potential reversal. Directional Bias: Given the proximity to the 60-day low of $266.71 and the current RSI, there is room for a bounce back towards the moving averages. However, caution is warranted as the stock is still under resistance from MA30 and MA50. Trade Plan: - Suggested Entry: $310.00 (slightly above current close to confirm upward movement) - Stop Loss: $295.00 (to limit risk) - Take Profit Targets: 1. $320.00 (3.2% gain) 2. $335.00 (8.7% gain) 3. $360.00 (16.8% gain) This plan provides a potential ROI of over 17% on the third target while maintaining a favorable risk-reward ratio. https://privateprofiteers.com
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 11 at 11:47 PM
$BIO: The current market context shows a last close at $311.94, with an RSI of 56.28 indicating a neutral to slightly bullish momentum. The price is currently below both the 30-day MA (314.4) and the 50-day MA (314.54), suggesting potential resistance ahead. However, the 60-day high of $343.12 provides an upside target, while the 60-day low of $266.71 establishes a solid support level. Directional bias leans bullish due to the RSI being above 50, indicating potential upward movement. Suggested trade plan: - Entry: $312.50 (slightly above last close) - Stop Loss: $303.87 (below recent support, approximately 2.5% risk) - Take Profit Targets: 1. $325.00 (4% gain) 2. $335.00 (7% gain) 3. $365.00 (17% gain) This plan offers a favorable risk-reward ratio with a potential ROI of over 17% on the third target. https://privateprofiteers.com
0 · Reply
RocketshipCalls
RocketshipCalls Dec. 10 at 3:14 PM
$SAVA 🧲 The current setup (why people are watching again) You now have: • CEO buying (confidence ✅) • Compressed price (optionality ✅) • Historical squeeze behavior (volatility ✅) • One of the largest unmet medical needs in history (Alzheimer’s ✅) That’s why SAVA doesn’t die — it reloads. $SPY $BIO $SRPT Get ready for a squeeze soon! One good catalyst and we squeeze! Huge short cover incoming!
1 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 10 at 3:51 AM
$BIO Actionable Trade Alert: Market Context: $BIO closed at $308.05, showing potential for upward movement given the current RSI of 50.22, indicating neutrality but room for growth. The 30-day moving average (MA30) at $315.16 and the 50-day moving average (MA50) at $313.57 suggest a resistance zone above the current price, but the proximity to these levels indicates a potential breakout. Directional Bias: With the 60-day high at $343.12 and the low at $266.71, there's a significant range that can be exploited. The ATR of 9.38 supports a volatility-based approach, allowing for strategic entry and exit points. Trade Plan: - Suggested Entry: $310.00 (above recent resistance) - Stop Loss: $300.00 (below recent support) - Take Profit Targets: 1. $320.00 (3.23% ROI) 2. $335.00 (8.71% ROI) 3. $362.00 (17.53% ROI) This plan targets a potential 17% ROI on the third take profit while maintaining a manageable risk. https://privateprofiteers.com
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 8 at 11:39 PM
$BIO: Current market context shows a last close at $313.18, with an RSI of 57.72 indicating a neutral to slightly bullish momentum. The price is near the 30-day moving average (MA30) of $316.25 and above the 50-day moving average (MA50) of $312.90, suggesting potential upward movement. The 60-day high of $343.12 provides a resistance level, while the low of $266.71 indicates solid support. Actionable Trade Alert: - Suggested Entry: $314.00 (slightly above the last close) - Stop Loss: $303.10 (below recent support) - Take Profit Targets: 1. Target 1: $320.00 (2% gain) 2. Target 2: $330.00 (5.4% gain) 3. Target 3: $367.00 (17.2% gain) Directional bias is bullish due to the RSI positioning and proximity to moving averages. Monitor the ATR of $10.08 for volatility. Execute this plan to capitalize on potential upward momentum. https://privateprofiteers.com
0 · Reply
Latest News on BIO
Bio-Rad Reports Third-Quarter 2025 Financial Results

Oct 29, 2025, 4:15 PM EDT - 2 months ago

Bio-Rad Reports Third-Quarter 2025 Financial Results


7 Stocks Taking The Next Step To Be On Offense

Oct 23, 2025, 7:30 PM EDT - 2 months ago

7 Stocks Taking The Next Step To Be On Offense

ACI CNX FCF FDX FIS IAC KHC


Bio-Rad Reports Second-Quarter 2025 Financial Results

Jul 31, 2025, 4:15 PM EDT - 5 months ago

Bio-Rad Reports Second-Quarter 2025 Financial Results


Bio-Rad Reports First-Quarter 2025 Financial Results

May 1, 2025, 4:15 PM EDT - 8 months ago

Bio-Rad Reports First-Quarter 2025 Financial Results


Bio-Rad Laboratories, Inc. (BIO) Q4 2024 Earnings Call Transcript

Feb 13, 2025, 11:45 PM EST - 11 months ago

Bio-Rad Laboratories, Inc. (BIO) Q4 2024 Earnings Call Transcript


Bio-Rad Reports Third-Quarter 2024 Financial Results

Oct 30, 2024, 4:15 PM EDT - 1 year ago

Bio-Rad Reports Third-Quarter 2024 Financial Results


Bio-Rad Reports Second-Quarter 2024 Financial Results

Aug 1, 2024, 4:15 PM EDT - 1 year ago

Bio-Rad Reports Second-Quarter 2024 Financial Results


Bio-Rad Reports First-Quarter 2024 Financial Results

May 7, 2024, 4:15 PM EDT - 1 year ago

Bio-Rad Reports First-Quarter 2024 Financial Results


Bio-Rad Announces Life Science Group Management Changes

Apr 26, 2024, 8:30 AM EDT - 1 year ago

Bio-Rad Announces Life Science Group Management Changes


Bio-Rad's Chief Operating Officer Andrew Last to Retire

Apr 10, 2024, 4:15 PM EDT - 1 year ago

Bio-Rad's Chief Operating Officer Andrew Last to Retire


DarylFarley1
DarylFarley1 Dec. 25 at 8:35 PM
$BIO $EH $XXRP $EMN High volume bottoming out
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 25 at 2:39 PM
$BIO: Current market context shows a recent close at $301.75 with an RSI of 29.02, indicating oversold conditions. The price is below both the 30-day MA of $312.43 and the 50-day MA of $314.84, suggesting bearish sentiment. However, the substantial gap from the 60-day high of $343.12 presents a potential reversal opportunity. Directional bias leans bullish due to the oversold RSI, which often signals a rebound. The 60-day low of $280.61 provides a solid support level. Trade Plan: - Suggested Entry: $302.50 - Stop Loss: $290.00 (below 60D low for risk management) - Take Profit Targets: 1. $315.00 (5% ROI) 2. $325.00 (7.7% ROI) 3. $353.00 (17% ROI) This plan capitalizes on potential bullish momentum while managing risk effectively. Monitor market conditions closely for any shifts. https://privateprofiteers.com
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Dec. 25 at 1:53 PM
$BIO RSI: 29.02, MACD: -3.5929 Vol: 8.88, MA20: 311.20, MA50: 314.84 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 19 at 4:34 PM
$BIO: Current market context shows a potential reversal opportunity. With the last close at $299.86 and an RSI of 20.56, the stock is significantly oversold, suggesting a bullish bias. The MA30 at $313.22 and MA50 at $314.80 indicate resistance levels above, while the 60D high of $343.12 provides a target for upward movement. Actionable Trade Alert: - Suggested Entry: $300.00 - Stop Loss: $280.00 (7% below entry) - Take Profit Targets: 1. Target 1: $320.00 (6.67% ROI) 2. Target 2: $335.00 (11.67% ROI) 3. Target 3: $350.00 (16.67% ROI) With a favorable risk-reward ratio, this trade plan aims for a minimum 16.67% ROI on the third target. The stock's current position within the high-low range supports potential upside movement. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 17 at 3:21 AM
$BIO: The stock closed at $302.02, with an RSI of 18.32, indicating it is significantly oversold. This suggests a potential reversal, especially given the proximity to the 60D Low of $266.71. The MA30 and MA50 are at $313.88 and $314.77, respectively, indicating resistance levels that could be targets for recovery. Actionable Trade Alert: - Suggested Entry: $302.02 - Stop Loss: $290.00 (3.98% below entry) - Take Profit Targets: 1. $320.00 (5.95% gain) 2. $335.00 (10.90% gain) 3. $353.00 (17.00% gain) Market context shows a potential upward movement as the stock is at a low point, and the RSI suggests a bounce back. The ATR of 8.41 indicates volatility, allowing for wider price movements. The directional bias is bullish due to the oversold condition and potential for recovery towards the MA levels. For further insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 15 at 6:53 AM
$BIO Actionable Trade Alert: Market Context: $BIO is currently trading at $308.13, below both the 30-day (MA30) and 50-day (MA50) moving averages, indicating a bearish trend. The RSI at 42.49 suggests the stock is nearing oversold territory, which could signal a potential reversal. Directional Bias: Given the proximity to the 60-day low of $266.71 and the current RSI, there is room for a bounce back towards the moving averages. However, caution is warranted as the stock is still under resistance from MA30 and MA50. Trade Plan: - Suggested Entry: $310.00 (slightly above current close to confirm upward movement) - Stop Loss: $295.00 (to limit risk) - Take Profit Targets: 1. $320.00 (3.2% gain) 2. $335.00 (8.7% gain) 3. $360.00 (16.8% gain) This plan provides a potential ROI of over 17% on the third target while maintaining a favorable risk-reward ratio. https://privateprofiteers.com
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 11 at 11:47 PM
$BIO: The current market context shows a last close at $311.94, with an RSI of 56.28 indicating a neutral to slightly bullish momentum. The price is currently below both the 30-day MA (314.4) and the 50-day MA (314.54), suggesting potential resistance ahead. However, the 60-day high of $343.12 provides an upside target, while the 60-day low of $266.71 establishes a solid support level. Directional bias leans bullish due to the RSI being above 50, indicating potential upward movement. Suggested trade plan: - Entry: $312.50 (slightly above last close) - Stop Loss: $303.87 (below recent support, approximately 2.5% risk) - Take Profit Targets: 1. $325.00 (4% gain) 2. $335.00 (7% gain) 3. $365.00 (17% gain) This plan offers a favorable risk-reward ratio with a potential ROI of over 17% on the third target. https://privateprofiteers.com
0 · Reply
RocketshipCalls
RocketshipCalls Dec. 10 at 3:14 PM
$SAVA 🧲 The current setup (why people are watching again) You now have: • CEO buying (confidence ✅) • Compressed price (optionality ✅) • Historical squeeze behavior (volatility ✅) • One of the largest unmet medical needs in history (Alzheimer’s ✅) That’s why SAVA doesn’t die — it reloads. $SPY $BIO $SRPT Get ready for a squeeze soon! One good catalyst and we squeeze! Huge short cover incoming!
1 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 10 at 3:51 AM
$BIO Actionable Trade Alert: Market Context: $BIO closed at $308.05, showing potential for upward movement given the current RSI of 50.22, indicating neutrality but room for growth. The 30-day moving average (MA30) at $315.16 and the 50-day moving average (MA50) at $313.57 suggest a resistance zone above the current price, but the proximity to these levels indicates a potential breakout. Directional Bias: With the 60-day high at $343.12 and the low at $266.71, there's a significant range that can be exploited. The ATR of 9.38 supports a volatility-based approach, allowing for strategic entry and exit points. Trade Plan: - Suggested Entry: $310.00 (above recent resistance) - Stop Loss: $300.00 (below recent support) - Take Profit Targets: 1. $320.00 (3.23% ROI) 2. $335.00 (8.71% ROI) 3. $362.00 (17.53% ROI) This plan targets a potential 17% ROI on the third take profit while maintaining a manageable risk. https://privateprofiteers.com
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 8 at 11:39 PM
$BIO: Current market context shows a last close at $313.18, with an RSI of 57.72 indicating a neutral to slightly bullish momentum. The price is near the 30-day moving average (MA30) of $316.25 and above the 50-day moving average (MA50) of $312.90, suggesting potential upward movement. The 60-day high of $343.12 provides a resistance level, while the low of $266.71 indicates solid support. Actionable Trade Alert: - Suggested Entry: $314.00 (slightly above the last close) - Stop Loss: $303.10 (below recent support) - Take Profit Targets: 1. Target 1: $320.00 (2% gain) 2. Target 2: $330.00 (5.4% gain) 3. Target 3: $367.00 (17.2% gain) Directional bias is bullish due to the RSI positioning and proximity to moving averages. Monitor the ATR of $10.08 for volatility. Execute this plan to capitalize on potential upward momentum. https://privateprofiteers.com
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 6 at 2:39 AM
$BIO: Current market context shows a stable price at $320.06, with an RSI of 52.44 indicating neutral momentum. The price is above the 30-day MA of $317.84 and significantly above the 50-day MA of $311.12, suggesting a bullish trend. The 60-day high of $343.12 provides a potential resistance level, while the low of $266.71 indicates strong support. Actionable Trade Alert: - Suggested Entry: $320.06 - Stop Loss: $310.00 (approx. 3% below entry) - Take Profit Targets: 1. $330.00 (3.1% gain) 2. $340.00 (6.2% gain) 3. $375.00 (17.2% gain) With the current price above key moving averages and a neutral RSI, the bullish bias is supported by the potential to reach the 60-day high. Execute this trade plan to capitalize on upward momentum. https://privateprofiteers.com
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 5 at 10:13 PM
$BIO: Current market context shows a stable price at $320.06, with an RSI of 52.44 indicating neutral momentum. The price is above the 30-day MA of $317.84 and significantly above the 50-day MA of $311.12, suggesting a bullish trend. The 60-day high of $343.12 provides a potential resistance level, while the low of $266.71 indicates strong support. Actionable Trade Alert: - Suggested Entry: $320.06 - Stop Loss: $310.00 (approx. 3% below entry) - Take Profit Targets: 1. $330.00 (3.1% gain) 2. $340.00 (6.2% gain) 3. $375.00 (17.2% gain) With the current price above key moving averages and a neutral RSI, the bullish bias is supported by the potential to reach the 60-day high. Execute this trade plan to capitalize on upward momentum. https://privateprofiteers.com
0 · Reply
BillionerOfKing
BillionerOfKing Dec. 4 at 6:53 PM
$BIO Current Stock Price: $318.34 Contracts to trade: $320 BIO Dec 19 2025 Call Entry: $3.00 Exit: $5.75 ROI: 92% Hold ~30 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
SuperGreenToday
SuperGreenToday Nov. 13 at 3:21 PM
$BIO Share Price: $325.39 Contract Selected: Jun 18, 2026 $370 Calls Buy Zone: $12.75 – $15.75 Target Zone: $20.46 – $25.00 Potential Upside: 52% ROI Time to Expiration: 216 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
BEATOFtheMARKET
BEATOFtheMARKET Nov. 9 at 9:29 PM
0 · Reply
SuperGreenToday
SuperGreenToday Nov. 5 at 3:09 AM
$BIO Share Price: $311.51 Contract Selected: Jun 18, 2026 $370 Calls Buy Zone: $8.50 – $10.50 Target Zone: $15.04 – $18.38 Potential Upside: 67% ROI Time to Expiration: 225 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
BEATOFtheMARKET
BEATOFtheMARKET Nov. 4 at 9:17 PM
0 · Reply
MKRReformed
MKRReformed Oct. 21 at 4:46 PM
$ADVB great intraday move so far bro $BIO $NERV $VSEE
1 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 17 at 7:27 PM
Enter: $BIO NOV 21 2025 $320 CALLS Buy in Price: $9.75 - $15.00 Take Profit: $15.31 Stop Bleeding: $8.58 ROI Potential: 57% Exit Within: 2 Weeks https://moneygroup.us/alerts
0 · Reply
Wigglyick
Wigglyick Oct. 16 at 8:38 PM
That sound you hear is the sucking chest wound in my acct…. But……some things working but not enough to matter, lol. $VEEV $BWXT $ANET $BIO had a good day, though I don’t own it yet
0 · Reply